Effect of Senobi Versus Buteyko Technique on Functional Performance of Chronic Obstructive Pulmonary Disease Patient.

January 28, 2024 updated by: Riphah International University

Effect of Senobi Breathing Exercise Versus Buteyko Breathing Technique on the Functional Performance Among Chronic Obstructive Pulmonary Disease Patient.

Effect of Senobi breathing exercise versus Buteyko breathing technique on functional performance among chronic obstructive pulmonary patient.

Study Overview

Status

Completed

Conditions

Detailed Description

chronic obstructive pulmonary disease is a chronic inflammatory lung disease that cause obstructed airflow from the lungs. Symptoms include Breathing difficulty. cough, mucus production and wheezing. Its typically caused by long term exposure to irritating gasses or particulate matter, most often from cigarette smoker.

Emphysema and chronic bronchitis are two most common condition that contribute to chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease is progressive disease that gets over a time. Clinical trials will be Conducted in Gulab Devi chest hospital in Lahore. Through the convenient sampling Technique. Which will be allocated through the random sampling two groups are involved group A and group B. In group A check the effect of Senobi techniques (stretch the body) and in group B check the effect of Buteyko technique. (Inhale the through the nose while mouth is closed) by using 6 mint walk test, Borg scale and quality of life questionnaire. Apply the technique to check the effectiveness of dyspnea and quality of life of patient The Buteyko technique offers a complementary method of reliving respiratory symptoms based on the voluntary control of breathing as well as considering the effect of environmental and dietary trigger. Data will be collected by the questionnaire and analyzed by using statistical package for the social science SPSS software version 21. The Buteyko method made its way to Australia to Europe and the unite states in 1990, it become best for the asthma and chronic obstructive pulmonary disease patient. The Senobi stretch exercise of the respiratory muscle improve the chest expansion and also improve the chest wall mobility in chronic obstructive pulmonary disease patient. Senobi breathing exercise was found to be effective for depression and it regulate the sympathetic nerve activity.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Lahore, Punjab, Pakistan, 54000
        • Gulab Devi Chest Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 40 -80
  • COPD patient in stage 2 (GOLD criteria)
  • Dyspnea (FEV1< 70 %)(26)
  • Maximum expiratory pressure: 50%
  • Smoker

Exclusion Criteria:

  • Patient with Tumor
  • Patient with Cardiac Arrhythmias Patient
  • Patient with cancer
  • insulin dependent diabetes
  • patient with thyroid disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Buteyko technique

GROUP A'(Buteyko technique)

Participant in group A will be instructed to perform the Buteyko breathing exercise.

Patient either on the sitting position or standing position.

Patient will be relaxed the shoulder and rest lower back against the back of chair.

Close the mouth while only breathing through nose.

Breath into the diaphragm and chest should be still.

Exhale slowly, then hold the breath.

Use the index finger and thumb to plug the nose, Hold the breath until there is urge to breath Then inhale

Repeat several times. With in 15 minutes.

pursed lip breathing
Other Names:
  • Senobi technique
Active Comparator: Senobi technique

GROUP B (Senobi techniques)

Senobi breathing exercise will be performed from standing, Arms will be extended firmly,

The neck was extended so as face the ceiling. And the patient instructed to avoid over exertion

Take a deep breath, hold for 3 second and then exhale through mouth.

The time of exercise will be 15 minutes.

pursed lip breathing
Other Names:
  • Senobi technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CASA Q (cough and sputum )
Time Frame: 4 weeks
The cough and sputum assessment questionnaire (CASA-Q) was used to measure the severity and impact of cough and sputum in patients with COPD and chronic bronchitis. CASA-Q scores of each domain demonstrated significant association with HRQoL impairment CASA-Q was strongly lower when chronic bronchitis was present, but multivariate analyses demonstrated that the association of HRQoL impairment was greater with the cough impact domain score than with the usual definition of chronic bronchitis. The CASA-Q targets cough and sputum by an original approach assessing both the symptoms and impacts in dailyactivities within the last 7 days. Each item is answered ranging from never to always or from not at all to a lot / extremely as applicable each type is answered using five categories.
4 weeks
Dyspnea rating scale.
Time Frame: 4 weeks
This scale is used for the measurement of the dyspnea ( shortness of breath ).This scale is questionnaire that consist of 5 breathlessness grade ,and the number 5 have maximum dyspnea
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sumera abdulhameed, ms, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 20, 2023

Primary Completion (Actual)

December 1, 2023

Study Completion (Actual)

December 10, 2023

Study Registration Dates

First Submitted

November 22, 2023

First Submitted That Met QC Criteria

December 25, 2023

First Posted (Actual)

January 9, 2024

Study Record Updates

Last Update Posted (Actual)

January 30, 2024

Last Update Submitted That Met QC Criteria

January 28, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shortness of Breath

Clinical Trials on pursed lip breathing

Subscribe